Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Jemincare, Kite, Moderna, Ose, Regeneron, Tetra.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Becton Dickinson, Bluestar Genomics, Inspire.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Autolus, Beyondspring, Lannett, Moderna, Neurophth, Respirent, Sanofi, Secura, Taiho, United.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dialco Medical, Neuropace, Oxehealth, Premia Spine.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Affimed, Amryt, Celltrion, Cstone, CTI, Everest, Evive, Exelixis, Innovent, Ipsen, Jazz, Mabxience, Nkmax, Opthea, Provention, SK, Surface Oncology, Syndax, Zai.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Akebia, Ascentage, Astellas, Biontech, Cansino, Celltrion, Chemrar, Glaxosmithkline, Horizon, Incyte, Insmed, JCR, Merck, Mezzion, Pfizer, RDIF, Samsung Bioepis, Seagen, Shanghai Henlius, Takeda, Union, Vertex, Vir.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Becton Dickinson, Binx Health, Gold Standard Diagnostics, Nines.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, ABL, Akebia, Amarin, Biom, Cara, Curevo, Eisai, Genmab, Horizon, I-Mab, Incyte, Intellia, JCR, Karyopharm, Merck, Moleculin, Myovant Sciences, PTC, RDIF, Stoke, Tiziana, Tetra, Vifor.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Helius Medical Technologies, Medtronic, Qiagen, STS Lab.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amryt, Antibe, Bluebird, Bristol Myers Squibb, Celltrion, Henlius, Mezzion, Merck & Co., Mirum, Myovant, Nymox, Paion, Pfizer, Rocket, Samsung, TG, Union, Xenetic.